Slow Capital Inc. Grows Stake in The Clorox Company (NYSE:CLX)

Slow Capital Inc. grew its stake in shares of The Clorox Company (NYSE:CLX) by 0.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,462 shares of the company’s stock after acquiring an additional 142 shares during the period. Slow Capital Inc.’s holdings in Clorox were worth $2,998,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CLX. State Street Corp grew its stake in Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC boosted its holdings in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC grew its position in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp lifted its holdings in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp grew its holdings in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE:CLX opened at $162.35 on Tuesday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market cap of $20.10 billion, a price-to-earnings ratio of 56.57, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a 50-day moving average price of $163.66 and a 200-day moving average price of $157.66.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $0.49 EPS. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities analysts anticipate that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is currently 170.04%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CLX shares. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Finally, Evercore ISI cut their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.